Infrastructure & support

A sophisticated infrastructure exists in Glasgow for undertaking the kinds of complex and multifaceted research and development required within the life sciences to produce commercial solutions. With property costs up to 75% lower than London and 11% lower than Cambridge (FDI Benchmark), Glasgow City is a cost-effective choice with ideal options for high-tech R&D efforts.

The support infrastructure specific to life sciences research and development is a mixture of initiatives, property opportunities/science parks/development and enterprise areas and financial incentives.

  • West of Scotland Science Park, 3 miles from Glasgow city centre, is a hub for technology companies on two campuses. Companies engaged in biotech, optoelectronics and software development are the primary tenants on the campuses. Because the park is located in a designated development area, those locating in the park are eligible for a number of government financial incentives. Already located in the park are Alba Ultrasound, Bio Reliance Biotech Ltd, BioOutsource and Glasgow Memory Clinic.
  • BioCity Scotland is the eastern boundary of the Glasgow BioCorridor. 13 companies have set up in the centre and have access to business advice and support as well as the laboratory and equipment available at the BioCity. The BioCity endeavour is marked by partnerships with universities in order to enable high-growth, innovative development by bio-entrepreneurs. Already located at BioCity are Insignia Technologies, Enocell, Pharmacells and Cytobiosis Research Ltd.  BioCity Scotland also hosts the European Lead Factory, a novel platform for innovative drug discovery.
  • Hillington Park Innovation Centre in Hillington Business Park offers onsite advisory and modern facilities.
  • Scottish Enterprise Technology Park in East Kilbride offers both startups and larger businesses an environment for innovation and development.
  • Irvine Innovation and Industry (i3) in North Ayrshire is the largest designated enterprise area in Scotland with 132 ha of allocated land.  i3 offers life science businesses either enhanced capital allowances or business rates relief.

 

 


Fill out the form below and one of our experts will contact you. Office hours are Monday - Friday, 9:00 - 17:00.







Briefly describe how we can help. Please be as specific as you can with your enquiry so that we can efficiently deal with your query.


captcha


University of Glasgow and NHS Greater Glasgow and Clyde establish the Glasgow Health Sciences Partnership

The University of Glasgow and NHS Greater Glasgow and Clyde (NHSGGC) today signed a Memorandum of Agreement (MOA) to form the Glasgow Health Sciences Partnership (GHSP). The aim of...Read More

£56m investment in BioCorridor to strengthen the UK’s place in the global pharma industry

A new £56 million UK innovation centre, which will revolutionise how medicines are manufactured, is to be located in Renfrewshire, part of the Glasgow BioCorridor. UK to capture a...Read More

US life sciences firm BioClavis sets up base in Glasgow

BioClavis has announced the planned creation of 43 new jobs with a £10.5 million investment supported by Scottish Enterprise. Bioclavis is a new spin-out from Californian molecular profiling company...Read More

Life Sciences Events

State of the City Economy Conference

7 December, 2018

Time: 8.00am

Venue: Radisson Blu Hotel Glasgow

Email Alerts

Sign-up to our email updates for the latest investment opportunities and information in Glasgow. Fill out the form below with your email.